Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy.

Autor: Turner N; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hamidi S; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ouni R; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Rico R; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Henderson YC; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Puche M; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Biology, College of Science and Engineering, Houston Christian University, Houston, TX, United States., Alekseev S; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Program of Biology, College of Sciences, The University of Texas at San Antonio, San Antonio, TX, United States., Colunga-Minutti JG; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Program of Immunology, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, TX, United States., Zafereo ME; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kim ST; Department of Rheumatology, Allergy and Immunology, Yale University, New Haven, CT, United States., Cabanillas ME; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Nurieva R; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Program of Immunology, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences (GSBS), Houston, TX, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 May 29; Vol. 15, pp. 1369780. Date of Electronic Publication: 2024 May 29 (Print Publication: 2024).